Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Psoriasis Drug market report explains the definition, types, applications, major countries, and major players of the Psoriasis Drug market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Valeant
Pfizer
Galderma
Bristol-Myers Squibb
Novartis
AbbVie
Merz Pharma
Bayer
Johnson & Johnson
LEO Pharma
GlaxoSmithKline
By Type:
External Use
Oral
Injection
By End-User:
Hospital
Drugs Store
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Psoriasis Drug Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Psoriasis Drug Outlook to 2028- Original Forecasts
-
2.2 Psoriasis Drug Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Psoriasis Drug Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Psoriasis Drug Market- Recent Developments
-
6.1 Psoriasis Drug Market News and Developments
-
6.2 Psoriasis Drug Market Deals Landscape
7 Psoriasis Drug Raw Materials and Cost Structure Analysis
-
7.1 Psoriasis Drug Key Raw Materials
-
7.2 Psoriasis Drug Price Trend of Key Raw Materials
-
7.3 Psoriasis Drug Key Suppliers of Raw Materials
-
7.4 Psoriasis Drug Market Concentration Rate of Raw Materials
-
7.5 Psoriasis Drug Cost Structure Analysis
-
7.5.1 Psoriasis Drug Raw Materials Analysis
-
7.5.2 Psoriasis Drug Labor Cost Analysis
-
7.5.3 Psoriasis Drug Manufacturing Expenses Analysis
8 Global Psoriasis Drug Import and Export Analysis (Top 10 Countries)
-
8.1 Global Psoriasis Drug Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Psoriasis Drug Export by Region (Top 10 Countries) (2017-2028)
9 Global Psoriasis Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Psoriasis Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global External Use Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Oral Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Injection Consumption and Growth Rate (2017-2022)
-
9.2 Global Psoriasis Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Drugs Store Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Psoriasis Drug Market Analysis and Outlook till 2022
-
10.1 Global Psoriasis Drug Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Psoriasis Drug Consumption (2017-2022)
-
10.2.2 Canada Psoriasis Drug Consumption (2017-2022)
-
10.2.3 Mexico Psoriasis Drug Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Psoriasis Drug Consumption (2017-2022)
-
10.3.2 UK Psoriasis Drug Consumption (2017-2022)
-
10.3.3 Spain Psoriasis Drug Consumption (2017-2022)
-
10.3.4 Belgium Psoriasis Drug Consumption (2017-2022)
-
10.3.5 France Psoriasis Drug Consumption (2017-2022)
-
10.3.6 Italy Psoriasis Drug Consumption (2017-2022)
-
10.3.7 Denmark Psoriasis Drug Consumption (2017-2022)
-
10.3.8 Finland Psoriasis Drug Consumption (2017-2022)
-
10.3.9 Norway Psoriasis Drug Consumption (2017-2022)
-
10.3.10 Sweden Psoriasis Drug Consumption (2017-2022)
-
10.3.11 Poland Psoriasis Drug Consumption (2017-2022)
-
10.3.12 Russia Psoriasis Drug Consumption (2017-2022)
-
10.3.13 Turkey Psoriasis Drug Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Psoriasis Drug Consumption (2017-2022)
-
10.4.2 Japan Psoriasis Drug Consumption (2017-2022)
-
10.4.3 India Psoriasis Drug Consumption (2017-2022)
-
10.4.4 South Korea Psoriasis Drug Consumption (2017-2022)
-
10.4.5 Pakistan Psoriasis Drug Consumption (2017-2022)
-
10.4.6 Bangladesh Psoriasis Drug Consumption (2017-2022)
-
10.4.7 Indonesia Psoriasis Drug Consumption (2017-2022)
-
10.4.8 Thailand Psoriasis Drug Consumption (2017-2022)
-
10.4.9 Singapore Psoriasis Drug Consumption (2017-2022)
-
10.4.10 Malaysia Psoriasis Drug Consumption (2017-2022)
-
10.4.11 Philippines Psoriasis Drug Consumption (2017-2022)
-
10.4.12 Vietnam Psoriasis Drug Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Psoriasis Drug Consumption (2017-2022)
-
10.5.2 Colombia Psoriasis Drug Consumption (2017-2022)
-
10.5.3 Chile Psoriasis Drug Consumption (2017-2022)
-
10.5.4 Argentina Psoriasis Drug Consumption (2017-2022)
-
10.5.5 Venezuela Psoriasis Drug Consumption (2017-2022)
-
10.5.6 Peru Psoriasis Drug Consumption (2017-2022)
-
10.5.7 Puerto Rico Psoriasis Drug Consumption (2017-2022)
-
10.5.8 Ecuador Psoriasis Drug Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Psoriasis Drug Consumption (2017-2022)
-
10.6.2 Kuwait Psoriasis Drug Consumption (2017-2022)
-
10.6.3 Oman Psoriasis Drug Consumption (2017-2022)
-
10.6.4 Qatar Psoriasis Drug Consumption (2017-2022)
-
10.6.5 Saudi Arabia Psoriasis Drug Consumption (2017-2022)
-
10.6.6 United Arab Emirates Psoriasis Drug Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Psoriasis Drug Consumption (2017-2022)
-
10.7.2 South Africa Psoriasis Drug Consumption (2017-2022)
-
10.7.3 Egypt Psoriasis Drug Consumption (2017-2022)
-
10.7.4 Algeria Psoriasis Drug Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Psoriasis Drug Consumption (2017-2022)
-
10.8.2 New Zealand Psoriasis Drug Consumption (2017-2022)
11 Global Psoriasis Drug Competitive Analysis
-
11.1 Valeant
-
11.1.1 Valeant Company Details
-
11.1.2 Valeant Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Valeant Psoriasis Drug Main Business and Markets Served
-
11.1.4 Valeant Psoriasis Drug Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Pfizer
-
11.2.1 Pfizer Company Details
-
11.2.2 Pfizer Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Pfizer Psoriasis Drug Main Business and Markets Served
-
11.2.4 Pfizer Psoriasis Drug Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Galderma
-
11.3.1 Galderma Company Details
-
11.3.2 Galderma Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Galderma Psoriasis Drug Main Business and Markets Served
-
11.3.4 Galderma Psoriasis Drug Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Bristol-Myers Squibb
-
11.4.1 Bristol-Myers Squibb Company Details
-
11.4.2 Bristol-Myers Squibb Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Bristol-Myers Squibb Psoriasis Drug Main Business and Markets Served
-
11.4.4 Bristol-Myers Squibb Psoriasis Drug Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Novartis
-
11.5.1 Novartis Company Details
-
11.5.2 Novartis Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Novartis Psoriasis Drug Main Business and Markets Served
-
11.5.4 Novartis Psoriasis Drug Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 AbbVie
-
11.6.1 AbbVie Company Details
-
11.6.2 AbbVie Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 AbbVie Psoriasis Drug Main Business and Markets Served
-
11.6.4 AbbVie Psoriasis Drug Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Merz Pharma
-
11.7.1 Merz Pharma Company Details
-
11.7.2 Merz Pharma Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Merz Pharma Psoriasis Drug Main Business and Markets Served
-
11.7.4 Merz Pharma Psoriasis Drug Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Bayer
-
11.8.1 Bayer Company Details
-
11.8.2 Bayer Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Bayer Psoriasis Drug Main Business and Markets Served
-
11.8.4 Bayer Psoriasis Drug Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Johnson & Johnson
-
11.9.1 Johnson & Johnson Company Details
-
11.9.2 Johnson & Johnson Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Johnson & Johnson Psoriasis Drug Main Business and Markets Served
-
11.9.4 Johnson & Johnson Psoriasis Drug Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 LEO Pharma
-
11.10.1 LEO Pharma Company Details
-
11.10.2 LEO Pharma Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 LEO Pharma Psoriasis Drug Main Business and Markets Served
-
11.10.4 LEO Pharma Psoriasis Drug Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 GlaxoSmithKline
-
11.11.1 GlaxoSmithKline Company Details
-
11.11.2 GlaxoSmithKline Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 GlaxoSmithKline Psoriasis Drug Main Business and Markets Served
-
11.11.4 GlaxoSmithKline Psoriasis Drug Product Portfolio
-
11.11.5 Recent Research and Development Strategies
12 Global Psoriasis Drug Market Outlook by Types and Applications to 2028
-
12.1 Global Psoriasis Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global External Use Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Psoriasis Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Drugs Store Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Psoriasis Drug Market Analysis and Outlook to 2028
-
13.1 Global Psoriasis Drug Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Psoriasis Drug Consumption Forecast (2022-2028)
-
13.2.2 Canada Psoriasis Drug Consumption Forecast (2022-2028)
-
13.2.3 Mexico Psoriasis Drug Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Psoriasis Drug Consumption Forecast (2022-2028)
-
13.3.2 UK Psoriasis Drug Consumption Forecast (2022-2028)
-
13.3.3 Spain Psoriasis Drug Consumption Forecast (2022-2028)
-
13.3.4 Belgium Psoriasis Drug Consumption Forecast (2022-2028)
-
13.3.5 France Psoriasis Drug Consumption Forecast (2022-2028)
-
13.3.6 Italy Psoriasis Drug Consumption Forecast (2022-2028)
-
13.3.7 Denmark Psoriasis Drug Consumption Forecast (2022-2028)
-
13.3.8 Finland Psoriasis Drug Consumption Forecast (2022-2028)
-
13.3.9 Norway Psoriasis Drug Consumption Forecast (2022-2028)
-
13.3.10 Sweden Psoriasis Drug Consumption Forecast (2022-2028)
-
13.3.11 Poland Psoriasis Drug Consumption Forecast (2022-2028)
-
13.3.12 Russia Psoriasis Drug Consumption Forecast (2022-2028)
-
13.3.13 Turkey Psoriasis Drug Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Psoriasis Drug Consumption Forecast (2022-2028)
-
13.4.2 Japan Psoriasis Drug Consumption Forecast (2022-2028)
-
13.4.3 India Psoriasis Drug Consumption Forecast (2022-2028)
-
13.4.4 South Korea Psoriasis Drug Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Psoriasis Drug Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Psoriasis Drug Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Psoriasis Drug Consumption Forecast (2022-2028)
-
13.4.8 Thailand Psoriasis Drug Consumption Forecast (2022-2028)
-
13.4.9 Singapore Psoriasis Drug Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Psoriasis Drug Consumption Forecast (2022-2028)
-
13.4.11 Philippines Psoriasis Drug Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Psoriasis Drug Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Psoriasis Drug Consumption Forecast (2022-2028)
-
13.5.2 Colombia Psoriasis Drug Consumption Forecast (2022-2028)
-
13.5.3 Chile Psoriasis Drug Consumption Forecast (2022-2028)
-
13.5.4 Argentina Psoriasis Drug Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Psoriasis Drug Consumption Forecast (2022-2028)
-
13.5.6 Peru Psoriasis Drug Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Psoriasis Drug Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Psoriasis Drug Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Psoriasis Drug Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Psoriasis Drug Consumption Forecast (2022-2028)
-
13.6.3 Oman Psoriasis Drug Consumption Forecast (2022-2028)
-
13.6.4 Qatar Psoriasis Drug Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Psoriasis Drug Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Psoriasis Drug Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Psoriasis Drug Consumption Forecast (2022-2028)
-
13.7.2 South Africa Psoriasis Drug Consumption Forecast (2022-2028)
-
13.7.3 Egypt Psoriasis Drug Consumption Forecast (2022-2028)
-
13.7.4 Algeria Psoriasis Drug Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Psoriasis Drug Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Psoriasis Drug Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Psoriasis Drug
-
Figure of Psoriasis Drug Picture
-
Table Global Psoriasis Drug Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Psoriasis Drug Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global External Use Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Injection Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Drugs Store Consumption and Growth Rate (2017-2022)
-
Figure Global Psoriasis Drug Consumption by Country (2017-2022)
-
Table North America Psoriasis Drug Consumption by Country (2017-2022)
-
Figure United States Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure Canada Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure Mexico Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Psoriasis Drug Consumption by Country (2017-2022)
-
Figure Germany Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure UK Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure Spain Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure Belgium Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure France Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure Italy Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure Denmark Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure Finland Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure Norway Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure Sweden Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure Poland Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure Russia Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure Turkey Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Table APAC Psoriasis Drug Consumption by Country (2017-2022)
-
Figure China Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure India Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure Thailand Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure Singapore Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure Philippines Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Table South America Psoriasis Drug Consumption by Country (2017-2022)
-
Figure Brazil Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure Colombia Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure Chile Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure Argentina Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure Peru Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Table GCC Psoriasis Drug Consumption by Country (2017-2022)
-
Figure Bahrain Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure Oman Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure Qatar Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Table Africa Psoriasis Drug Consumption by Country (2017-2022)
-
Figure Nigeria Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure South Africa Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure Egypt Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure Algeria Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Table Oceania Psoriasis Drug Consumption by Country (2017-2022)
-
Figure Australia Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Table Valeant Company Details
-
Table Valeant Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Valeant Psoriasis Drug Main Business and Markets Served
-
Table Valeant Psoriasis Drug Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Psoriasis Drug Main Business and Markets Served
-
Table Pfizer Psoriasis Drug Product Portfolio
-
Table Galderma Company Details
-
Table Galderma Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Galderma Psoriasis Drug Main Business and Markets Served
-
Table Galderma Psoriasis Drug Product Portfolio
-
Table Bristol-Myers Squibb Company Details
-
Table Bristol-Myers Squibb Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Psoriasis Drug Main Business and Markets Served
-
Table Bristol-Myers Squibb Psoriasis Drug Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Psoriasis Drug Main Business and Markets Served
-
Table Novartis Psoriasis Drug Product Portfolio
-
Table AbbVie Company Details
-
Table AbbVie Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Psoriasis Drug Main Business and Markets Served
-
Table AbbVie Psoriasis Drug Product Portfolio
-
Table Merz Pharma Company Details
-
Table Merz Pharma Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merz Pharma Psoriasis Drug Main Business and Markets Served
-
Table Merz Pharma Psoriasis Drug Product Portfolio
-
Table Bayer Company Details
-
Table Bayer Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Psoriasis Drug Main Business and Markets Served
-
Table Bayer Psoriasis Drug Product Portfolio
-
Table Johnson & Johnson Company Details
-
Table Johnson & Johnson Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Psoriasis Drug Main Business and Markets Served
-
Table Johnson & Johnson Psoriasis Drug Product Portfolio
-
Table LEO Pharma Company Details
-
Table LEO Pharma Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table LEO Pharma Psoriasis Drug Main Business and Markets Served
-
Table LEO Pharma Psoriasis Drug Product Portfolio
-
Table GlaxoSmithKline Company Details
-
Table GlaxoSmithKline Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Psoriasis Drug Main Business and Markets Served
-
Table GlaxoSmithKline Psoriasis Drug Product Portfolio
-
Figure Global External Use Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drugs Store Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Psoriasis Drug Consumption Forecast by Country (2022-2028)
-
Table North America Psoriasis Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Psoriasis Drug Consumption Forecast by Country (2022-2028)
-
Figure Germany Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Psoriasis Drug Consumption Forecast by Country (2022-2028)
-
Figure China Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Psoriasis Drug Consumption Forecast by Country (2022-2028)
-
Figure Brazil Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Psoriasis Drug Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Psoriasis Drug Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Psoriasis Drug Consumption Forecast by Country (2022-2028)
-
Figure Australia Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
